Related Experiment Video
Updated: Jul 6, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Type 2 diabetes candidate gene CAPN10: first, but not last
Martin Ridderstråle1, Emma Nilsson
1Department of Clinical Sciences, Clinical Obesity, Malmö University Hospital, Lund University, S-205 02, Malmö, Sweden. martin.ridderstrale@med.lu.se
Current Hypertension Reports
|March 28, 2008
Summary
The CAPN10 gene was the first identified susceptibility gene for type 2 diabetes mellitus (T2DM). While initially linked to T2DM risk, subsequent studies show mixed results, and CAPN10 is not a top signal in recent genome-wide association studies.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- The CAPN10 gene, encoding calpain 10, was the first identified genetic susceptibility locus for type 2 diabetes mellitus (T2DM).
- An early finding associated a specific haplotype of CAPN10 (UCSNP-43, -19, -63) with increased T2DM risk in the discovery population.
- Subsequent research on the CAPN10-T2DM association across diverse populations has yielded conflicting results.
Purpose of the Study:
- To review the genetic evidence linking CAPN10 to T2DM.
- To discuss the current understanding of calpain 10's biological functions.
- To contextualize CAPN10 findings within recent genome-wide association study (GWAS) results.
Main Methods:
- Review of published genetic association studies for CAPN10 and T2DM.
- Analysis of functional data implicating calpain 10 in glucose metabolism and pancreatic beta-cell function.
- Comparison of original linkage findings with recent GWAS data.
Main Results:
- Conflicting evidence exists regarding the association between CAPN10 genetic variants and T2DM risk across different populations.
- Calpain 10 is implicated in glucose transporter 4 translocation, insulin secretion, and beta-cell apoptosis.
- Recent large-scale GWAS have not identified CAPN10 as a major T2DM susceptibility gene.
Conclusions:
- The role of CAPN10 in T2DM pathogenesis remains uncertain due to inconsistent genetic findings.
- Further research is needed to elucidate the precise biological mechanisms of calpain 10 in glucose homeostasis and diabetes.
- Despite initial promise, CAPN10 is not currently considered a primary genetic factor for T2DM based on large-scale genetic studies.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...